CD4 and neoplasm: G-CSF/G-CSFR increased the secretion of FoxP3-expressing CD4+ and CD8+ T cells, while G-CSFR deficiency in T cells increased cytotoxic activity in the tumor microenvironment by producing IL-17A which improved resistance to anti-PD-1 therapy [136–138].